Tradipitant Prevents Motion Sickness in Phase 3 Trial
Tradipitant was found to be superior to placebo in preventing vomiting tied to motion sickness, according to results from a phase 3 study.
Source: empr.com
Stay updated with breaking news from Motion Syros. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tradipitant was found to be superior to placebo in preventing vomiting tied to motion sickness, according to results from a phase 3 study.
WASHINGTON, May 25, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. today announced the results from its Phase III study of tradipitant in motion sickness, confirming the previously reported... | May 25, 2023
Tradipitant was found to be superior to placebo in preventing vomiting tied to motion sickness, according to results from a phase 3 study.